Adalimumab

September 26, 2014September 26, 2014

FDA Approves Humira for Pediatric Crohn’s Disease

Crohn's Disease, News

Abbvie reported today that the U.S. Food and Drug Administration (FDA) has approved HUMIRA® (adalimumab) as a new treatment for Crohn’s disease in children over six years of age, when other treatments ... Read more

September 9, 2014September 9, 2014

Long-term Use of Adalimumab Yields Promising Benefits For Ulcerative Colitis Patients

News, Ulcerative colitis

According to a recent study, prolonged treatment with Adalimumab, a TNF inhibiting anti-inflammatory drug, is beneficial for patients with moderately to severely active ulcerative colitis (UC). The study was conducted at the University ... Read more

August 29, 2014September 28, 2016

ULTRA 1, 2, 3 Demonstrate Safety and Efficacy of Adalimumab in Ulcerative Colitis

News, Ulcerative colitis

Three clinical trials — one an open-label extension study, evaluating adalimumab (Humira) in patients with moderately to severely active ulcerative colitis — were recently reviewed in an article from collaborators at ... Read more